Dupilumab Prefilled Syringe

DRUG4 trials

Sponsors

University Hospital, Toulouse, Jonathan A. Bernstein, MD, University of Virginia, Université de Sherbrooke

Conditions

Asthma ControlAtopic DermatitisEczemaNasal PolypsNetherton SyndromeStaphylococcus Aureus

Phase 2

A Pilot Study of the Efficacy and Safety of Dupilumab Versus Placebo in Patients With Netherton Syndrome

University Hospital, ToulouseNetherton Syndrome

Start: 2020-07-23End: 2024-06-01Target: 24Updated: 2023-08-23

Phase 3

A Study Assessing the Effect of Dupilumab on Inducing Clinical Remission in Asthma

RecruitingNCT07309614

Université de SherbrookeAsthma Control

Start: 2026-01-29End: 2030-01-01Target: 150Updated: 2026-09-04

Phase 4

The Utility of Functionally Relevant Signature Genes in Assessing the Clinical Outcomes of Dupilumab Treatment

CompletedNCT04358224

Jonathan A. Bernstein, MDAtopic Dermatitis, Eczema

Start: 2020-09-01End: 2022-11-18Updated: 2023-02-08

Interleukin-4Ra Blockade by Dupilumab Decreases Staphylococcus Colonization and Increases Microbial Diversity in CRSwNP

RecruitingNCT05094570

University of VirginiaNasal Polyps, Staphylococcus Aureus

Start: 2022-09-01End: 2026-12-31Target: 20Updated: 2025-04-01